Archive · 15 Aug 2025
Piyush Goyal Meets Pharma Leaders to Boost Competitiveness
India's Commerce Minister met with leaders from the country's pharmaceutical companies.
They talked about how to make Indian drug companies stronger and do more research.
This is part of a plan to make India self-reliant and a global leader in manufacturing.
The government is working with the industry to assess the effects of possible new taxes from the US, with pharmaceuticals being among the sectors exempt from the tariffs.
The goal is to boost the industry, which already sends a lot of its products to the US.
Commerce Minister Piyush Goyal met with Indian pharmaceutical industry leaders.
The meeting focused on strategies to enhance competitiveness and R&D.
The discussions align with the 'Aatmanirbhar Bharat' and 'Make In India' initiatives.
Pharmaceuticals are exempt from potential US reciprocal tariffs.
India's pharma exports to the US comprised approximately 40% of total exports in FY2025.
- Who
- Piyush Goyal and pharmaceutical industry leaders
- What
- Meeting between Commerce Minister and pharmaceutical industry leaders to discuss strategies to boost competitiveness and R&D.
- When
- August 15
- Where
- New Delhi, India
- Why
- To enhance India's position in the global healthcare value chain and align with 'Aatmanirbhar Bharat' and 'Make In India' visions.
Potential Impact of US Reciprocal Tariffs
Strategic Path Forward
Tariff impact
Potential Impact of US Reciprocal Tariffs
Concerns over impact
Strategic Path Forward
Pharmaceuticals exempt
- Meeting Purpose
- Boost Competitiveness & R&D
- Key Participants
- Piyush Goyal & Pharma Leaders
- Focus
- Pharmaceutical Industry
- Policy Alignment
- 'Aatmanirbhar Bharat' & 'Make In India'
- US Tariff Impact
- Pharmaceuticals Exempt
- FY2025 Pharma Exports to US
- ~40%
